Search

Your search keyword '"Buchan G"' showing total 263 results

Search Constraints

Start Over You searched for: Author "Buchan G" Remove constraint Author: "Buchan G"
263 results on '"Buchan G"'

Search Results

109. Equivalent radiation exposure with robotic total hip replacement using a novel, fluoroscopic-guided (CT-free) system: case-control study versus manual technique.

110. PPM1D mutations are oncogenic drivers of de novo diffuse midline glioma formation.

111. Primary saturation of α, β-unsaturated carbonyl containing fatty acids does not abolish electrophilicity.

112. Cohort profile for the STratifying Resilience and Depression Longitudinally (STRADL) study: A depression-focused investigation of Generation Scotland, using detailed clinical, cognitive, and neuroimaging assessments.

113. The Root Lesion Nematode Effector Ppen10370 Is Essential for Parasitism of Pratylenchus penetrans .

114. Cohort profile for the STratifying Resilience and Depression Longitudinally (STRADL) study: A depression-focused investigation of Generation Scotland, using detailed clinical, cognitive, and neuroimaging assessments.

115. Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma.

116. Fly Stampede 2.0: A Next Generation Optomotor Assay for Walking Behavior in Drosophila Melanogaster .

117. Combined introduction of Bmi-1 and hTERT immortalizes human adipose tissue-derived stromal cells with low risk of transformation.

118. The use of Th1 cytokines, IL-12 and IL-23, to modulate the immune response raised to a DNA vaccine delivered by gene gun.

119. Murine antigen-presenting cells are multifunctional in vitro biosensors for detecting the immunoactive potential of bovine milk products.

120. A prolonged immune response to antigen delivered in poly (epsilon-caprolactone) microparticles.

121. Manipulation of immune responses to Mycobacterium bovis by vaccination with IL-2- and IL-18-secreting recombinant bacillus Calmette Guerin.

122. In vitro control of Mycobacterium bovis by macrophages.

123. The production and biological assessment of cervine interferon gamma.

124. Targeting early events in T cell activation to construct improved vaccines.

125. The expression and biologic effects of ovine interleukin-4 on T and B cell proliferation.

126. Ontario familial colon cancer registry: methods and first-year response rates.

127. Vaccine protocols to optimise the protective efficacy of BCG.

128. The characterisation of a cervine immunoregulatory cytokine, interleukin 12.

129. Vaccination for the new millennium.

130. Toward a stepped care approach to treating problem drinkers: the predictive utility of within-treatment variables and therapist prognostic ratings.

131. Aftercare telephone contacts with problem drinkers can serve a clinical and research function.

132. The cloning, expression and purification of cervine interleukin 2.

133. T cell responses to Mycobacterium bovis in red deer, a large animal model for tuberculosis.

134. Animal models of protective immunity in tuberculosis to evaluate candidate vaccines.

135. The cloning and sequencing of cervine interleukin 10.

136. Cloning and sequencing of expressed DRB genes of the red deer (Cervus elaphus) Mhc.

137. BCG vaccination in deer: distinctions between delayed type hypersensitivity and laboratory parameters of immunity.

138. Vaccination against tuberculosis: is BCG more sinned against than sinner?

139. Detection of proliferating cell nuclear antigens and interleukin-2 beta receptor molecules on mitogen- and antigen-stimulated lymphocytes.

140. Comparison of immunocytochemical and Holzer's methods for detection of acute and chronic gliosis in human postmortem material.

141. Cervine T-lymphocyte growth factors and their measurement in tuberculosis.

142. Tuberculosis in domesticated red deer: comparison of purified protein derivative and the specific protein MPB70 for in vitro diagnosis.

143. Cytokine production in the rheumatoid joint: implications for treatment.

144. Identification of heterologous monoclonal antibodies that cross-react with cervine leukocyte subpopulations.

145. Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis.

147. Detection of activated T cell products in the rheumatoid joint using cDNA probes to Interleukin-2 (IL-2) IL-2 receptor and IFN-gamma.

148. The response of human peripheral blood mononuclear phagocytes to rheumatoid arthritis.

Catalog

Books, media, physical & digital resources